Table 3 Fractional incorporation rate (FIR) and rate of appearance (Ra) of U13C- potassium palmitate (16.0) and U13C-potassium linoleate (18.2 n-6) of athletes and patients with type 2 diabetes mellitus before and after exercise interventions
From: Comparison of intramyocellular lipid metabolism in patients with diabetes and male athletes
Baseline differences between athletes and type 2 diabetes patients | p-value | Athletes change between baseline and deconditioning | p-value | Patients with type 2 diabetes change between baseline and exercise training | p-value | Difference in changes between athletes and type 2 diabetes patients | p-value | |
|---|---|---|---|---|---|---|---|---|
FIR 16.0 (%/h) | 0.46 (0.18–0.76) | 0.003 | −0.27 (−0.57 to 0.3) | 0.07 | 0.2 (0.002–0.4) | 0.04 | −0.5 (−0.8 to −0.1) | 0.008 |
FIR 18.0 n-6 (%/h) | 0.15 (0.05–0.24) | 0.003 | −0.06 (−0.16 to 0.05) | 0.3 | 0.095 (0.1–0.17) | 0.02 | −0.15 (−0.27 to −0.02) | 0.01 |
Ra 16.0 (mmol/h) | 0.7 (−0.9 to 2.3) | 0.4 | −0.8 (−2.2 to 0.7) | 0.2 | −0.09 (−1.3 to 1.1) | 0.9 | −0.7 (−2.4 to 1.0) | 0.4 |
Ra 18.2 n-6 (mmol/h) | −0.6 (−2.2 to 1.0) | 0.4 | −0.234 (−1.1 to 0.6) | 0.5 | −0.204 (−1.2 to 0.8) | 0.7 | −0.03 (−1.3 to 1.2) | 0.9 |
